Auricular Acupressure for Preventing Postoperative Catheter-Related Bladder Discomfort in Male Patients Undergoing Spinal Surgery: A Randomized Controlled Trial.
Yang Dong, Dingde Long, Bei Fang, Shui-Gen Song, Peng Liao, Tian-Yuan Li, Lei Li
{"title":"Auricular Acupressure for Preventing Postoperative Catheter-Related Bladder Discomfort in Male Patients Undergoing Spinal Surgery: A Randomized Controlled Trial.","authors":"Yang Dong, Dingde Long, Bei Fang, Shui-Gen Song, Peng Liao, Tian-Yuan Li, Lei Li","doi":"10.1155/nrp/3182987","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims and objectives: </strong>This present study evaluated the utility of auricular acupressure (AA) in alleviating catheter-related bladder discomfort (CRBD).</p><p><strong>Background: </strong>The efficacy and safety of current treatments for postoperative CRBD in male patients remain suboptimal.</p><p><strong>Design: </strong>A randomized, placebo-controlled trial was conducted.</p><p><strong>Methods: </strong>This trial enrolled male patients postlumbar surgery from 1 July 2024 to 31 August 2024. Participants were allocated to an AA group (Group AA, <i>n</i> = 40) or a placebo control group (Group C, <i>n</i> = 40). Both groups received 3 days of intervention prior to surgery. Outcomes included the following: Moderate-to-severe CRBD at extubation; 24-h postoperative opioid requirement; CRBD severity (none/mild/moderate-to-severe) at 1, 6, and 24 h postextubation; postoperative pain; and patient satisfaction. Data were analyzed via SPSS 23 using <i>t</i>-tests, chi-square tests, and repeated-measures ANOVA.</p><p><strong>Results: </strong>In this randomized trial of 80 male spinal surgery patients, AA significantly reduced moderate-to-severe CRBD incidence at extubation (T1): 22.5% (9/40) in Group AA vs. 52.5% (21/40) in Group C (RR: 0.263; 95% CI: 0.100-0.691; <i>p</i> = 0.006). AA decreased the subjects of 24-h supplemental opioid requirements (17.5% vs. 37.5%; RR: 2.829; 95% CI: 1.003-7.977; <i>p</i> = 0.045) and elevated patient satisfaction (median 5.0 vs. 4.0; <i>p</i> = 0.034). No between-group differences existed in morphine-equivalent consumption or CRBD severity beyond T1 (<i>p</i> > 0.05).</p><p><strong>Conclusions: </strong>AA is an effective, nonpharmacological intervention that reduces early postoperative CRBD severity and opioid demand while enhancing recovery satisfaction in catheterized males. As a noninvasive, side-effect-free intervention, AA warrants integration into enhanced recovery after surgery (ERAS) protocols for catheterized patients. <b>Trial Registration:</b> Chinese Registry of Clinical Trials: ChiCTR2400086089.</p>","PeriodicalId":46917,"journal":{"name":"Nursing Research and Practice","volume":"2026 ","pages":"3182987"},"PeriodicalIF":2.5000,"publicationDate":"2026-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13291715/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nursing Research and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/nrp/3182987","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
Aims and objectives: This present study evaluated the utility of auricular acupressure (AA) in alleviating catheter-related bladder discomfort (CRBD).
Background: The efficacy and safety of current treatments for postoperative CRBD in male patients remain suboptimal.
Design: A randomized, placebo-controlled trial was conducted.
Methods: This trial enrolled male patients postlumbar surgery from 1 July 2024 to 31 August 2024. Participants were allocated to an AA group (Group AA, n = 40) or a placebo control group (Group C, n = 40). Both groups received 3 days of intervention prior to surgery. Outcomes included the following: Moderate-to-severe CRBD at extubation; 24-h postoperative opioid requirement; CRBD severity (none/mild/moderate-to-severe) at 1, 6, and 24 h postextubation; postoperative pain; and patient satisfaction. Data were analyzed via SPSS 23 using t-tests, chi-square tests, and repeated-measures ANOVA.
Results: In this randomized trial of 80 male spinal surgery patients, AA significantly reduced moderate-to-severe CRBD incidence at extubation (T1): 22.5% (9/40) in Group AA vs. 52.5% (21/40) in Group C (RR: 0.263; 95% CI: 0.100-0.691; p = 0.006). AA decreased the subjects of 24-h supplemental opioid requirements (17.5% vs. 37.5%; RR: 2.829; 95% CI: 1.003-7.977; p = 0.045) and elevated patient satisfaction (median 5.0 vs. 4.0; p = 0.034). No between-group differences existed in morphine-equivalent consumption or CRBD severity beyond T1 (p > 0.05).
Conclusions: AA is an effective, nonpharmacological intervention that reduces early postoperative CRBD severity and opioid demand while enhancing recovery satisfaction in catheterized males. As a noninvasive, side-effect-free intervention, AA warrants integration into enhanced recovery after surgery (ERAS) protocols for catheterized patients. Trial Registration: Chinese Registry of Clinical Trials: ChiCTR2400086089.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
